An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus

NCT02561078 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Human regular U-500 insulin (CSII)
DRUG: Human regular U-500 insulin (MDI)

Sponsor

Eli Lilly and Company

Collaborators

[object Object]